A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

NCT01712061 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
226
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer